Yahoo Finance's Brooke DiPalma breaks down WW International's nutrition program incorporating popular weight loss drugs and how pharmaceutical stocks are responding.
The weight-loss platform is launching a new plan, the WeightWatchers GLP-1 Program, for those who are obese or overweight and taking any of the increasingly popular injectable drugs that help with cur
If you want to follow Oprah Winfrey's latest plan for losing weight, be prepared to do, well, everything.
The "Motley Fool Money" crew takes a look at what's piquing investors' interest.
WW International stock's decline from highs seen over the Covid-19 pandemic can be attributed to the company's lower subscriber base, particularly in the digital busin

Ozempic vs. Mounjaro:: Battle of the bulge

10:16am, Monday, 04'th Dec 2023
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs in the medical sector, led by the popularity of Ozempic. Celebrity usage and social media exposure have caused Nov
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced that it will present at the following investor co
WW International, Inc. (NASDAQ:WW ) Q3 2023 Earnings Conference Call November 2, 2023 5:30 PM ET Company Participants Corey Kinger - Investor Relations Sima Sistani - Chief Executive Officer Heather S
WW International Inc. WW, +2.88%, formerly known as Weight Watchers, late Thursday missed the revenue forecast for its third quarter and said revenue for the year will come at the lower end of its exp
WW International has a long history of disappointing shareholders. So why does one bank predict more than 100% upside?

Why WW International Stock Slipped This Week

02:26pm, Friday, 27'th Oct 2023
WW International is the parent company of Weight Watchers. The company has seen declining sales for the last five years.
WW International's core Weight Watchers business is struggling with falling revenues and subscribers in a competitive market. The company's acquisition of Sequence Health to pivot into weight loss med
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the third quarter 2023 after market
The most famous individual associated with the weight-loss specialist made some remarks that were taken positively. She walked back previous utterances, which satisfied both the market and several ana
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE